March 6, 2026 · Form 4 insider transaction
Dier Mardi sold 40 shares of Madrigal Pharmaceuticals, Inc. at $425.08 per share, a transaction worth $17.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.